Results 141 to 150 of about 24,578 (265)

Diagnostic tests for urinary tract infections and antimicrobial resistance-a reality check between diagnostic innovation and implementation: a critical narrative review. [PDF]

Front Cell Infect Microbiol
Mohan V, Mitsakakis K.
europepmc   +1 more source

Fungal‐Bacterial Interactions in Polymicrobial Infections: Hidden Threats

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
ABSTRACT Polymicrobial infections involving fungi and bacteria represent a major and increasingly recognized clinical challenge, in which interkingdom interactions significantly amplify disease severity, antimicrobial resistance, and treatment failure. Rather than passive co‐existence, fungal–bacterial communities form highly coordinated systems driven
Mohammad Javad Roustaye Gourabi, Masoud Kargar, Atefeh Kamali, Javad Yasbolaghi Sharahi   +3 more
wiley   +1 more source

Carbapenem resistance in community-acquired urinary tract infections caused by <i>Klebsiella pneumoniae</i> and <i>Escherichia coli</i> in Morocco: a multicentre study (January 2022-December 2023): '<b>Carbapenem resistance in community UTIs in Morocco'</b>. [PDF]

JAC Antimicrob Resist
Khazaz A, El Otmani F, Benzaarate I, Bourjilat F, El Hamouchi A, Rafetrarivony LF, Huynh BT, Crucitti T, Brisse S, Nayme K.   +9 more
europepmc   +1 more source

Interplay Between Virulence Genes, Antimicrobial Resistance Profiles, and Biofilm Formation in Klebsiella pneumoniae Causing Urinary Tract Infections in North Lebanon

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
– Figure design (single panel) Central icon: K. pneumoniae cell Left panel – Virulence genes (icons): Adhesion: fimH, mrkD → strong biofilm Capsule/regulation: magA, rmpA Siderophores: entB, iucA → iron uptake Right panel – Outcomes: Biofilm strength (weak → strong gradient) Antibiotic resistance (ESBL, MDR) Bottom split: Hospital‐acquired → strong ...
Mazen Zaylaa, Rayan Farha, Jana Taleb, Amal Saad, Omar El Gharbawy, Ricardo Sarraf, Ibtihal Kassam, Chadi Hamdach, Nisrine Bissar   +8 more
wiley   +1 more source

Cases - Ehlers-Danlos syndromes: Review on the urologic implications. [PDF]

Can Urol Assoc J
Mohamud H, Matta R, Neu S.
europepmc   +1 more source

The Expanding Landscape of Microbiota Medicine: Indications, Therapeutic Modalities, and the Path Towards Integrative Microbiome‐Targeting Healthcare

Microbiota Medicine Research, Volume 1, Issue 2, Page 63-89, June 2026.
ABSTRACT The growing recognition of the microbiome’s role in human health has propelled the emergence of microbiota medicine—a new discipline integrating microbiology, multi‐omics, and clinical science. Advances in sequencing, data integration, and interventions such as fecal microbiota transplantation (FMT) have transitioned the field from ...
Min Dai, Yisha Lin, Renyou Gan, Xiaotao Shen, Shin Young Park, Sunjae Lee, Qi Su   +6 more
wiley   +1 more source

Molecular Characterization and Antibiotic Resistance of Broad-Spectrum <i>β</i>-Lactamase-Producing Enterobacterales in Urinary Tract Infections in Libreville, Gabon. [PDF]

Int J Microbiol
Yala JF, Minko OZ, Mabika RM, Mounioko F, Mbongo-Kama EA, Dikoumba AC, Souza A.   +6 more
europepmc   +1 more source

Phenotyping Overactive Bladder – Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI‐RS 2025

Neurourology and Urodynamics, Volume 45, Issue 5, Page 904-913, June 2026.
ABSTRACT Introduction Management of overactive bladder (OAB) has a stepwise approach in adults and children. This does not account for individual patient variations, which may explain suboptimal outcomes in many patients. Distinct OAB profiles, based on patient characteristics, symptoms, urodynamic findings and imaging have been discussed in Part 1 ...
Michel Wyndaele, Michael Samarinas, Apostolos Apostolidis, D. Carolina Ochoa, Giovanni Mosiello, Brigitte Schurch, Pradeep Tyagi, Alan Wein, Paul Abrams, John E. Speich   +9 more
wiley   +1 more source

The prevalence and predictor factors of urinary tract infection in type 2 diabetes mellitus patients receiving SGLT2 inhibitors in Qatar: A retrospective cohort study. [PDF]

J Pharm Policy Pract
Alhefel SH, Thomas B, Sherbash M, Hayder S, Ibrahim MI, Singh R, Alhefel AH, Abou Safrah S, Karawia A, Alyazeedi A.   +9 more
europepmc   +1 more source

UTI in Women

Annals of SBV, 2012
openaire   +1 more source